Research output per year
Research output per year
Personal profile
Headline
ADJUNCT PROFESSOR
Fingerprint
Dive into the research topics where Ze'Ev Ronai is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
An exploitable Achilles heel of MITF?
Silva, C. & Ronai, Z. A., Mar 2023, In: Cell Research. 33, 3, p. 195-196 2 p.Research output: Contribution to journal › Comment/debate
Open Access -
Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome
Dinstag, G., Shulman, E. D., Elis, E., Ben-Zvi, D. S., Tirosh, O., Maimon, E., Meilijson, I., Elalouf, E., Temkin, B., Vitkovsky, P., Schiff, E., Hoang, D. T., Sinha, S., Nair, N. U., Lee, J. S., Schäffer, A. A., Ronai, Z., Juric, D., Apolo, A. B., Dahut, W. L., & 11 others, 13 Jan 2023, In: Med. 4, 1, p. 15-30.e8Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Arginyl-tRNA-protein transferase 1 (ATE1) promotes melanoma cell growth and migration
Lazar, I., Fabre, B., Feng, Y., Khateb, A., Frit, P., Kashina, A., Zhang, T., Avitan-Hersh, E., Kim, H., Brown, K., Topisirovic, I. & Ronai, Z. A., Jun 2022, In: FEBS Letters. 596, 11, p. 1468-1480 13 p.Research output: Contribution to journal › Article › peer-review
-
Author Correction: A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing (Nature Communications, (2021), 12, 1, (6512), 10.1038/s41467-021-26788-6)
Sinha, S., Barbosa, K., Cheng, K., Leiserson, M. D. M., Jain, P., Deshpande, A., Wilson, D. M., Ryan, B. M., Luo, J., Ronai, Z. A., Lee, J. S., Deshpande, A. J. & Ruppin, E., Dec 2022, In: Nature Communications. 13, 1, 2828.Research output: Contribution to journal › Comment/debate
Open Access1 Scopus citations -
Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex
Feng, Y., Grotegut, S., Jovanovic, P., Gandin, V., Olson, S. H., Murad, R., Beall, A., Colayco, S., De-Jesus, P., Chanda, S., English, B. P., Singer, R. H., Jackson, M., Topisirovic, I. & Ronai, Z. A., 1 Dec 2022, In: Frontiers in Pharmacology. 13, 1029093.Research output: Contribution to journal › Article › peer-review
Open Access
Press/Media
-
-
Sanford Burnham Prebys Medical Discovery Institute: A Two-for-One Approach to Boost Melanoma Immunotherapy
6/07/23
1 item of Media coverage
Press/Media
-
U.S. Patents Awarded to Inventors in California (Feb. 14)
14/02/23
1 item of Media coverage
Press/Media
-
Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex [A549]
13/12/22
1 item of Media coverage
Press/Media
-
Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex [Vero E6]
13/12/22
2 items of Media coverage
Press/Media